EyePoint, Inc. (EYPT) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Eyepoint, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.856 Good morning. My name is Michelle and I'll be your conference operator today. 00:00:03.856 -- 00:00:09.363 At this time, I would like to welcome everyone to the iPoint fourth quarter 2025 financial 00:00:09.363 -- 00:00:12.988 results and recent corporate development conference call. 00:00:12.988 -- 00:00:17.313 There will be a question and answer session to follow at the completion of the prepared 00:00:17.313 -- 00:00:22.119 remarks. Please be advised that today's conference is being recorded at the company's 00:00:22.119 -- 00:00:27.353 request. I would now like to turn the call over to Greg Elston, Executive Vice 00:00:27.353 -- 00:00:29.937 President and Chief Financial Officer of iPoint. 00:00:29.937 -- 00:00:32.718 Sir, please go ahead. 00:00:33.702 -- 00:00:37.969 Thank you, and thank you all for joining us on today's conference call to discuss iPoint's 00:00:37.969 -- 00:00:43.717 fourth quarter and full year 2025 financial results and recent corporate developments. 00:00:43.717 -- 00:00:48.744 With me today is Dr. Jay Duker, President and Chief Executive Officer of iPoint. 00:00:48.744 -- 00:00:53.120 Jay will begin with a review of recent corporate updates and discuss our clinical programs 00:00:53.120 -- 00:00:58.265 for DuraView and wet AMD and DME. I will close with commentary on the fourth 00:00:58.265 -- 00:01:01.748 quarter and full year 2025 financial results. 00:01:01.748 -- 00:01:05.612 We will then open the call for your questions where we will be joined by Dr. 00:01:05.612 -- 00:01:10.477 Romero-Ribero, our chief medical officer, and Mike Campbell, our new chief commercial 00:01:10.477 -- 00:01:11.898 officer. 00:01:11.898 -- 00:01:16.182 Earlier this morning, we issued a press release detailing our financial ...